drugset
drugset / Trial / NCT02749578

Drug Interaction Study of MGL-3196 With Atorvastatin

NCT02749578 ↗

Phase 1 Completed 14 enrolled Madrigal Pharmaceuticals, Inc. Celerion · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of atorvastatin in healthy male subjects and female subjects not of child-bearing potential.

Timeline

Start
2016-04
Primary completion
2016-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule — —
Subject Resmetirom Small molecule — —

Indications

No indication recorded.